This inventor holds 2 USPTO granted patents. Top assignee: Connaught Laboratories Limited. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: Mary E Ewashysyn: Innovator in Respiratory Syncytial Virus Vaccines
Introduction
Mary E Ewashysyn is a prominent inventor based in Willowdale, CA. She has made significant contributions to the field of medical research, particularly in the development of vaccines for respiratory syncytial virus (RSV). With a total of 2 patents to her name, her work is paving the way for advancements in immunization and disease detection.
Latest Patents
Mary's latest patents focus on nucleic acid respiratory syncytial virus vaccines. These patents describe vectors containing a nucleotide sequence coding for an F protein of RSV, along with a promoter for such sequence, preferably a cytomegalovirus promoter. The vectors may also include an additional nucleotide sequence adjacent to the RSV F protein encoding sequence, which enhances the immunoprotective ability of the RSV F protein when expressed in vivo. These innovative vectors can be used to immunize hosts, including humans, and to produce antibodies for the detection of RSV infection in samples.
Career Highlights
Mary E Ewashysyn is associated with Connaught Laboratories Limited, where she continues to contribute to groundbreaking research in vaccine development. Her work has been instrumental in addressing public health challenges posed by respiratory viruses.
Collaborations
Mary has collaborated with notable colleagues, including Xiaomao Li and Michel Henri Klein, to further her research and enhance the effectiveness of her innovations.
Conclusion
Mary E Ewashysyn's contributions to the field of vaccine development, particularly for respiratory syncytial virus, highlight her role as a leading inventor in medical research. Her innovative approaches are crucial for advancing public health solutions.